ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 700

Clinical Correlation of Flow-Mediated Endothelium-Dependent Vasodilatation in Systemic Sclerosis

Takehiro Takahashi1, Yoshihide Asano1, Eisuke Amiya2, Masaru Hatano3, Atsuko Ozeki2, Aya Watanabe2, Shuichi Kawarasaki2, Tomoko Nakao2, Zenshiro Tamaki4, Takashi Taniguchi5, Yohei Ichimura5, Tetsuo Toyama1, Masafumi Watanabe6, Yasunobu Hirata2, Ryozo Nagai3 and Shinichi Sato7, 1Department of Dermatology, University of Tokyo Graduate School of Medicine, Tokyo, Japan, 2Department of Cardiovascular Medicine, University of Tokyo Graduate School of Medicine, Tokyo, Japan, 3Cardiovascular Medicine, University of Tokyo Graduate School of Medicine, Tokyo, Japan, 4Medicine, Rheumatology, Department of Dermatology, University of Tokyo Graduate School of Medicine, Tokyo, Japan, 5Dermatology, University of Tokyo Graduate School of Medicine, Tokyo, Japan, 6Cardiovascular Medicine, Department of Cardiovascular Medicine, University of Tokyo Graduate School of Medicine, Tokyo, Japan, 7Department of Dermatology, Faculty of Medicine, University of Tokyo, Tokyo, Japan

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: endothelial cells and systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Sclerosis, Fibrosing Syndromes, and Raynaud’s – Clinical Aspects and Therapeutics

Session Type: Abstract Submissions (ACR)

Background/Purpose: Systemic sclerosis (SSc) is a multisystem autoimmune disease characterized by initial vascular injuries and resultant fibrosis of skin and certain internal organs. Evidence has shown that vascular impairment in SSc may be a sign of endothelial dysfunction involving both microvascular and macrovascular systems. Ultrasound assessment of brachial artery endothelial-dependent flow-mediated dilation (FMD) is a noninvasive instrumental evaluation that is routinely performed as an index of macrovascular function. We evaluated the association of FMD with clinical features of SSc to assess the possible contribution of endothelial dysfunction to the developmental process of clinical features associated with this disease.

Methods: Twelve healthy controls and thirty-five consecutive patients with SSc (mean age 53 ± 17 years and 57 ± 11 years, respectively) were studied. In patients, clinical symptoms, such as swollen fingers, nailfold bleeding (NFB), pitting scars, digital ulcers, and Raynaud’s phenomenon, were meticulously recorded. Eighteen patients had limited cutaneous SSc (lcSSc) and 17 had diffuse cutaneous SSc (dcSSc). Ultrasound assessment of FMD was performed on all patients. Correlation between FMD value (%FMD) and various typical symptoms, disease duration, and subtype of SSc was studied.

Results:  There was significant decrease in %FMD in patients compared to healthy controls (5.72% versus 7.71%, respectively; p = 0.041). Especially, lcSSc patients had significantly lower %FMD values than healthy controls (5.25% versus 7.6%, p = 0.016), while the levels in dcSSc patients (6.8%) were comparable to those of healthy controls. Furthermore, in lcSSc patient group, patients with decreased %FMD had much longer disease duration than those with normal %FMD (p = 0.0088), while the age of these two patient groups was comparable. As for clinical symptoms, lcSSc patients with decreased %FMD showed much higher prevalence of digital ulcers and elevated RVSP than those with normal %FMD (for each; 75% versus 10%, p = 0.040). In addition, there was a trend towards the increase in the prevalence of decreased %DLco, but not decreased %VC, in lcSSc patients with decreased %FMD as compared to those with normal %FMD.

Conclusion: Endothelial function evaluated by %FMD is markedly impaired in SSc patients. lcSSc patients with decreased %FMD exhibited a significantly higher prevalence of clinical symptoms associated with vasculopathy. Furthermore, the values of %FMD greatly and inversely correlated with disease duration in lcSSc patients. Collectively, %FMD is potentially a powerful tool to evaluate the damage of vascular system in SSc, especially in limited cutaneous subtype of this disease.


Disclosure:

T. Takahashi,
None;

Y. Asano,
None;

E. Amiya,
None;

M. Hatano,
None;

A. Ozeki,
None;

A. Watanabe,
None;

S. Kawarasaki,
None;

T. Nakao,
None;

Z. Tamaki,
None;

T. Taniguchi,
None;

Y. Ichimura,
None;

T. Toyama,
None;

M. Watanabe,
None;

Y. Hirata,
None;

R. Nagai,
None;

S. Sato,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/clinical-correlation-of-flow-mediated-endothelium-dependent-vasodilatation-in-systemic-sclerosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology